// src/lib/frozenResponses.ts

export const FROZEN_RESPONSES: Record<string, any> = {
  "did dupilumab receive fda approval for asthma before chronic rhinosinusitis": {
  "answer": "No, Dupilumab did not receive FDA approval for asthma before it was approved for chronic rhinosinusitis. The approval timeline indicates that Dupilumab was first approved for chronic rhinosinusitis with nasal polyps in June 2019, while its approval for asthma came later, in October 2018. This suggests that the sequence of approvals was not in favor of asthma preceding chronic rhinosinusitis.\n\nThe approval for chronic rhinosinusitis was based on its efficacy in treating patients with this condition, which highlights the importance of addressing chronic inflammatory diseases. The subsequent approval for asthma indicates that while Dupilumab is effective for multiple conditions, the initial focus was on chronic rhinosinusitis, which underscores the evolving understanding of the drug's therapeutic potential.",
  "overall_uncertainty": 0.4,
  "token_uncertainty": [
    { "token": "No,", "score": 0.1 },
    { "token": "Dupilumab", "score": 0.2 },
    { "token": "did", "score": 0.1 },
    { "token": "not", "score": 0.1 },
    { "token": "receive", "score": 0.3 },
    { "token": "FDA", "score": 0.2 },
    { "token": "approval", "score": 0.2 },
    { "token": "for", "score": 0.1 },
    { "token": "asthma", "score": 0.3 },
    { "token": "before", "score": 0.4 },
    { "token": "it", "score": 0.1 },
    { "token": "was", "score": 0.1 },
    { "token": "approved", "score": 0.2 },
    { "token": "chronic", "score": 0.3 },
    { "token": "rhinosinusitis.", "score": 0.2 },
    { "token": "The", "score": 0.1 },
    { "token": "approval", "score": 0.2 },
    { "token": "timeline", "score": 0.4 },
    { "token": "indicates", "score": 0.2 },
    { "token": "that", "score": 0.1 },
    { "token": "first", "score": 0.3 },
    { "token": "for", "score": 0.1 },
    { "token": "chronic", "score": 0.3 },
    { "token": "rhinosinusitis", "score": 0.4 },
    { "token": "with", "score": 0.1 },
    { "token": "nasal", "score": 0.3 },
    { "token": "polyps", "score": 0.4 },
    { "token": "in", "score": 0.1 },
    { "token": "June", "score": 0.5 },
    { "token": "2019,", "score": 0.6 },
    { "token": "while", "score": 0.2 },
    { "token": "its", "score": 0.1 },
    { "token": "approval", "score": 0.2 },
    { "token": "for", "score": 0.1 },
    { "token": "asthma", "score": 0.3 },
    { "token": "came", "score": 0.4 },
    { "token": "later,", "score": 0.5 },
    { "token": "in", "score": 0.1 },
    { "token": "October", "score": 0.5 },
    { "token": "2018.", "score": 0.6 },
    { "token": "This", "score": 0.1 },
    { "token": "suggests", "score": 0.3 },
    { "token": "that", "score": 0.1 },
    { "token": "the", "score": 0.1 },
    { "token": "sequence", "score": 0.4 },
    { "token": "of", "score": 0.1 },
    { "token": "approvals", "score": 0.3 },
    { "token": "was", "score": 0.1 },
    { "token": "not", "score": 0.1 },
    { "token": "in", "score": 0.1 },
    { "token": "favor", "score": 0.4 },
    { "token": "of", "score": 0.1 },
    { "token": "asthma", "score": 0.3 },
    { "token": "preceding", "score": 0.5 },
    { "token": "chronic", "score": 0.3 },
    { "token": "rhinosinusitis.", "score": 0.2 },
    { "token": "The", "score": 0.1 },
    { "token": "approval", "score": 0.2 },
    { "token": "for", "score": 0.1 },
    { "token": "chronic", "score": 0.3 },
    { "token": "rhinosinusitis", "score": 0.4 },
    { "token": "was", "score": 0.1 },
    { "token": "based", "score": 0.3 },
    { "token": "on", "score": 0.1 },
    { "token": "its", "score": 0.1 },
    { "token": "efficacy", "score": 0.4 },
    { "token": "in", "score": 0.1 },
    { "token": "treating", "score": 0.3 },
    { "token": "patients", "score": 0.4 },
    { "token": "with", "score": 0.1 },
    { "token": "this", "score": 0.1 },
    { "token": "condition,", "score": 0.4 },
    { "token": "which", "score": 0.2 },
    { "token": "highlights", "score": 0.3 },
    { "token": "the", "score": 0.1 },
    { "token": "importance", "score": 0.4 },
    { "token": "of", "score": 0.1 },
    { "token": "addressing", "score": 0.5 },
    { "token": "chronic", "score": 0.3 },
    { "token": "inflammatory", "score": 0.4 },
    { "token": "diseases.", "score": 0.5 },
    { "token": "The", "score": 0.1 },
    { "token": "subsequent", "score": 0.4 },
    { "token": "approval", "score": 0.2 },
    { "token": "for", "score": 0.1 },
    { "token": "asthma", "score": 0.3 },
    { "token": "indicates", "score": 0.2 },
    { "token": "that", "score": 0.1 },
    { "token": "while", "score": 0.2 },
    { "token": "Dupilumab", "score": 0.2 },
    { "token": "is", "score": 0.1 },
    { "token": "effective", "score": 0.3 },
    { "token": "for", "score": 0.1 },
    { "token": "multiple", "score": 0.4 },
    { "token": "conditions,", "score": 0.5 },
    { "token": "the", "score": 0.1 },
    { "token": "initial", "score": 0.4 },
    { "token": "focus", "score": 0.5 },
    { "token": "was", "score": 0.1 },
    { "token": "on", "score": 0.1 },
    { "token": "chronic", "score": 0.3 },
    { "token": "rhinosinusitis,", "score": 0.4 },
    { "token": "which", "score": 0.2 },
    { "token": "underscores", "score": 0.4 },
    { "token": "the", "score": 0.1 },
    { "token": "evolving", "score": 0.5 },
    { "token": "understanding", "score": 0.4 },
    { "token": "of", "score": 0.1 },
    { "token": "the", "score": 0.1 },
    { "token": "drug's", "score": 0.4 },
    { "token": "therapeutic", "score": 0.5 },
    { "token": "potential.", "score": 0.6 }
  ],
  "central_claim": "No, Dupilumab did not receive FDA approval for asthma before it was approved for chronic rhinosinusitis.",
  "relations": [
    {
      "source": "Dupilumab was first approved for chronic rhinosinusitis with nasal polyps in June 2019.",
      "type": "SUPPORTS",
      "target": "central_claim",
      "score": 0.2,
      "explanation": "This supports the claim because it shows that the approval for chronic rhinosinusitis occurred before the approval for asthma.",
      "relation_links": [
        { "url": "https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-treat-chronic-rhinosinusitis-nasal-polyps", "title": "FDA Approval for Chronic Rhinosinusitis" }
      ]
    },
    {
      "source": "The approval for asthma came later, in October 2018.",
      "type": "SUPPORTS",
      "target": "central_claim",
      "score": 0.3,
      "explanation": "This supports the claim because it confirms that asthma approval was not the first indication for Dupilumab.",
      "relation_links": [
        { "url": "https://www.fda.gov/news-events/press-announcements/fda-approves-dupilumab-asthma", "title": "FDA Approval for Asthma" }
      ]
    },
    {
      "source": "Dupilumab was initially focused on chronic rhinosinusitis treatment.",
      "type": "ATTACKS",
      "target": "central_claim",
      "score": 0.4,
      "explanation": "This attacks the claim because it suggests that the drug was primarily developed for asthma treatment.",
      "relation_links": [
        { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071234/", "title": "Dupilumab Development Focus" }
      ]
    },
    {
      "source": "The drug's efficacy in asthma was recognized early in its development.",
      "type": "ATTACKS",
      "target": "central_claim",
      "score": 0.5,
      "explanation": "This attacks the claim because it implies that asthma was a significant consideration during Dupilumab's approval process.",
      "relation_links": [
        { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071234/", "title": "Dupilumab Efficacy in Asthma" }
      ]
    }
  ],
  "links_paragraph": [
    { "url": "https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-treat-chronic-rhinosinusitis-nasal-polyps", "title": "FDA Approval for Chronic Rhinosinusitis" },
    { "url": "https://www.fda.gov/news-events/press-announcements/fda-approves-dupilumab-asthma", "title": "FDA Approval for Asthma" }
  ],
  "recommended_searches": {
    "paragraph_level": [],
    "token_level": [],
    "relation_level": []
  }
},

  "is there more antihistamine in benadryl than rhinocort": {
  "answer": "No, Benadryl contains a different formulation and dosage of antihistamine compared to Rhinocort. While Benadryl is primarily an antihistamine with diphenhydramine as its active ingredient, Rhinocort is a corticosteroid that works differently to reduce inflammation in the nasal passages. This distinction in their active ingredients and mechanisms of action suggests that Benadryl does not have more antihistamine than Rhinocort.\n\nThe comparison between these two medications highlights their different purposes in treating allergic symptoms. Benadryl is used for immediate relief of allergy symptoms, while Rhinocort is intended for long-term management of nasal allergy symptoms. This means that the presence of antihistamine in Benadryl does not equate to a higher concentration when compared to the corticosteroid action of Rhinocort, reinforcing the idea that Benadryl does not contain more antihistamine than Rhinocort.",
  "overall_uncertainty": 0.4,
  "token_uncertainty": [
    { "token": "No,", "score": 0.1 },
    { "token": "Benadryl", "score": 0.2 },
    { "token": "contains", "score": 0.3 },
    { "token": "a", "score": 0.1 },
    { "token": "different", "score": 0.4 },
    { "token": "formulation", "score": 0.5 },
    { "token": "and", "score": 0.1 },
    { "token": "dosage", "score": 0.3 },
    { "token": "of", "score": 0.1 },
    { "token": "antihistamine", "score": 0.2 },
    { "token": "compared", "score": 0.4 },
    { "token": "to", "score": 0.1 },
    { "token": "Rhinocort.", "score": 0.3 },
    { "token": "While", "score": 0.4 },
    { "token": "is", "score": 0.1 },
    { "token": "primarily", "score": 0.5 },
    { "token": "an", "score": 0.1 },
    { "token": "with", "score": 0.2 },
    { "token": "diphenhydramine", "score": 0.6 },
    { "token": "as", "score": 0.1 },
    { "token": "its", "score": 0.1 },
    { "token": "active", "score": 0.3 },
    { "token": "ingredient,", "score": 0.4 },
    { "token": "corticosteroid", "score": 0.7 },
    { "token": "that", "score": 0.1 },
    { "token": "works", "score": 0.2 },
    { "token": "differently", "score": 0.5 },
    { "token": "to", "score": 0.1 },
    { "token": "reduce", "score": 0.3 },
    { "token": "inflammation", "score": 0.6 },
    { "token": "in", "score": 0.1 },
    { "token": "the", "score": 0.1 },
    { "token": "nasal", "score": 0.3 },
    { "token": "passages.", "score": 0.4 },
    { "token": "This", "score": 0.1 },
    { "token": "distinction", "score": 0.5 },
    { "token": "their", "score": 0.1 },
    { "token": "active", "score": 0.3 },
    { "token": "ingredients", "score": 0.4 },
    { "token": "and", "score": 0.1 },
    { "token": "mechanisms", "score": 0.5 },
    { "token": "of", "score": 0.1 },
    { "token": "action", "score": 0.4 },
    { "token": "suggests", "score": 0.6 },
    { "token": "that", "score": 0.1 },
    { "token": "Benadryl", "score": 0.2 },
    { "token": "does", "score": 0.1 },
    { "token": "not", "score": 0.1 },
    { "token": "have", "score": 0.1 },
    { "token": "more", "score": 0.3 },
    { "token": "than", "score": 0.1 },
    { "token": "Rhinocort.", "score": 0.3 },
    { "token": "The", "score": 0.1 },
    { "token": "comparison", "score": 0.4 },
    { "token": "between", "score": 0.2 },
    { "token": "these", "score": 0.3 },
    { "token": "two", "score": 0.1 },
    { "token": "medications", "score": 0.4 },
    { "token": "highlights", "score": 0.5 },
    { "token": "their", "score": 0.1 },
    { "token": "different", "score": 0.4 },
    { "token": "purposes", "score": 0.5 },
    { "token": "in", "score": 0.1 },
    { "token": "treating", "score": 0.3 },
    { "token": "allergic", "score": 0.6 },
    { "token": "symptoms.", "score": 0.4 },
    { "token": "Benadryl", "score": 0.2 },
    { "token": "is", "score": 0.1 },
    { "token": "used", "score": 0.3 },
    { "token": "for", "score": 0.1 },
    { "token": "immediate", "score": 0.4 },
    { "token": "relief", "score": 0.5 },
    { "token": "of", "score": 0.1 },
    { "token": "allergy", "score": 0.6 },
    { "token": "symptoms,", "score": 0.4 },
    { "token": "while", "score": 0.4 },
    { "token": "Rhinocort", "score": 0.2 },
    { "token": "is", "score": 0.1 },
    { "token": "intended", "score": 0.5 },
    { "token": "for", "score": 0.1 },
    { "token": "long-term", "score": 0.4 },
    { "token": "management", "score": 0.5 },
    { "token": "of", "score": 0.1 },
    { "token": "nasal", "score": 0.3 },
    { "token": "allergy", "score": 0.6 },
    { "token": "symptoms.", "score": 0.4 },
    { "token": "This", "score": 0.1 },
    { "token": "means", "score": 0.4 },
    { "token": "that", "score": 0.1 },
    { "token": "the", "score": 0.1 },
    { "token": "presence", "score": 0.5 },
    { "token": "of", "score": 0.1 },
    { "token": "antihistamine", "score": 0.2 },
    { "token": "in", "score": 0.1 },
    { "token": "Benadryl", "score": 0.2 },
    { "token": "does", "score": 0.1 },
    { "token": "not", "score": 0.1 },
    { "token": "equate", "score": 0.6 },
    { "token": "to", "score": 0.1 },
    { "token": "a", "score": 0.1 },
    { "token": "higher", "score": 0.4 },
    { "token": "concentration", "score": 0.5 },
    { "token": "when", "score": 0.3 },
    { "token": "compared", "score": 0.4 },
    { "token": "to", "score": 0.1 },
    { "token": "the", "score": 0.1 },
    { "token": "corticosteroid", "score": 0.7 },
    { "token": "action", "score": 0.4 },
    { "token": "of", "score": 0.1 },
    { "token": "Rhinocort,", "score": 0.3 },
    { "token": "reinforcing", "score": 0.5 },
    { "token": "the", "score": 0.1 },
    { "token": "idea", "score": 0.4 },
    { "token": "that", "score": 0.1 },
    { "token": "Benadryl", "score": 0.2 },
    { "token": "does", "score": 0.1 },
    { "token": "not", "score": 0.1 },
    { "token": "contain", "score": 0.3 },
    { "token": "more", "score": 0.3 },
    { "token": "antihistamine", "score": 0.2 },
    { "token": "than", "score": 0.1 },
    { "token": "Rhinocort.", "score": 0.3 }
  ],
  "central_claim": "No, Benadryl does not contain more antihistamine than Rhinocort.",
  "relations": [
    {
      "source": "Benadryl is primarily an antihistamine, while Rhinocort is a corticosteroid.",
      "type": "SUPPORTS",
      "target": "central_claim",
      "score": 0.2,
      "explanation": "This supports the claim because the different classifications of these medications indicate that their active ingredients serve different purposes.",
      "relation_links": [
        { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461234/", "title": "Differences between antihistamines and corticosteroids" }
      ]
    },
    {
      "source": "Rhinocort is intended for long-term management of nasal allergy symptoms.",
      "type": "SUPPORTS",
      "target": "central_claim",
      "score": 0.3,
      "explanation": "This supports the claim because it emphasizes that Rhinocort does not function as an antihistamine, thus Benadryl cannot have more antihistamine than it.",
      "relation_links": [
        { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461234/", "title": "Corticosteroids in allergy treatment" }
      ]
    },
    {
      "source": "Benadryl is often used for immediate relief, while Rhinocort is for long-term use.",
      "type": "ATTACKS",
      "target": "central_claim",
      "score": 0.4,
      "explanation": "This attacks the claim because it suggests that Benadryl may have a more immediate effect due to its antihistamine properties, which could imply a higher relevance in certain contexts.",
      "relation_links": [
        { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461234/", "title": "Antihistamines for allergy relief" }
      ]
    },
    {
      "source": "The dosage of antihistamine in Benadryl is significant for its effectiveness.",
      "type": "ATTACKS",
      "target": "central_claim",
      "score": 0.5,
      "explanation": "This attacks the claim because it raises the possibility that the amount of antihistamine in Benadryl could be perceived as more effective in treating symptoms than Rhinocort.",
      "relation_links": [
        { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461234/", "title": "Dosage considerations in antihistamines" }
      ]
    }
  ],
  "links_paragraph": [
    { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461234/", "title": "Differences between antihistamines and corticosteroids" }
  ],
  "recommended_searches": {
    "paragraph_level": [],
    "token_level": [],
    "relation_level": []
  }
},

  "is deep vein thrombosis a common side effect of ocella": {
  "answer": "Yes, Deep Vein Thrombosis (DVT) can be a common side effect of Ocella, which is a combination oral contraceptive. The estrogen component in such contraceptives is known to increase the risk of thromboembolic events, including DVT, particularly in women who have additional risk factors such as obesity, smoking, or a history of clotting disorders.\n\nThe association between hormonal contraceptives and DVT is well-documented, suggesting that the use of Ocella may elevate the risk for some individuals. This means that women taking Ocella should be aware of the symptoms of DVT and consult their healthcare provider if they have concerns, as early detection and management are crucial for preventing serious complications.",
  "overall_uncertainty": 0.4,
  "token_uncertainty": [
    { "token": "Yes,", "score": 0.1 },
    { "token": "Deep", "score": 0.3 },
    { "token": "Vein", "score": 0.2 },
    { "token": "Thrombosis", "score": 0.2 },
    { "token": "(DVT)", "score": 0.1 },
    { "token": "can", "score": 0.2 },
    { "token": "be", "score": 0.1 },
    { "token": "a", "score": 0.1 },
    { "token": "common", "score": 0.4 },
    { "token": "side", "score": 0.3 },
    { "token": "effect", "score": 0.3 },
    { "token": "of", "score": 0.1 },
    { "token": "Ocella,", "score": 0.2 },
    { "token": "which", "score": 0.3 },
    { "token": "is", "score": 0.1 },
    { "token": "a", "score": 0.1 },
    { "token": "combination", "score": 0.4 },
    { "token": "oral", "score": 0.2 },
    { "token": "contraceptive.", "score": 0.3 },
    { "token": "The", "score": 0.1 },
    { "token": "estrogen", "score": 0.3 },
    { "token": "component", "score": 0.4 },
    { "token": "in", "score": 0.1 },
    { "token": "such", "score": 0.3 },
    { "token": "contraceptives", "score": 0.4 },
    { "token": "is", "score": 0.1 },
    { "token": "known", "score": 0.2 },
    { "token": "to", "score": 0.1 },
    { "token": "increase", "score": 0.3 },
    { "token": "the", "score": 0.1 },
    { "token": "risk", "score": 0.2 },
    { "token": "of", "score": 0.1 },
    { "token": "thromboembolic", "score": 0.4 },
    { "token": "events,", "score": 0.3 },
    { "token": "including", "score": 0.3 },
    { "token": "DVT,", "score": 0.2 },
    { "token": "particularly", "score": 0.4 },
    { "token": "in", "score": 0.1 },
    { "token": "women", "score": 0.2 },
    { "token": "who", "score": 0.1 },
    { "token": "have", "score": 0.1 },
    { "token": "additional", "score": 0.4 },
    { "token": "risk", "score": 0.2 },
    { "token": "factors", "score": 0.4 },
    { "token": "such", "score": 0.3 },
    { "token": "as", "score": 0.1 },
    { "token": "obesity,", "score": 0.4 },
    { "token": "smoking,", "score": 0.4 },
    { "token": "or", "score": 0.1 },
    { "token": "a", "score": 0.1 },
    { "token": "history", "score": 0.3 },
    { "token": "of", "score": 0.1 },
    { "token": "clotting", "score": 0.4 },
    { "token": "disorders.", "score": 0.3 },
    { "token": "The", "score": 0.1 },
    { "token": "association", "score": 0.4 },
    { "token": "between", "score": 0.1 },
    { "token": "hormonal", "score": 0.4 },
    { "token": "contraceptives", "score": 0.4 },
    { "token": "and", "score": 0.1 },
    { "token": "DVT", "score": 0.2 },
    { "token": "is", "score": 0.1 },
    { "token": "well-documented,", "score": 0.4 },
    { "token": "suggesting", "score": 0.3 },
    { "token": "that", "score": 0.1 },
    { "token": "the", "score": 0.1 },
    { "token": "use", "score": 0.2 },
    { "token": "of", "score": 0.1 },
    { "token": "Ocella", "score": 0.2 },
    { "token": "may", "score": 0.3 },
    { "token": "elevate", "score": 0.4 },
    { "token": "the", "score": 0.1 },
    { "token": "risk", "score": 0.2 },
    { "token": "for", "score": 0.1 },
    { "token": "some", "score": 0.3 },
    { "token": "individuals.", "score": 0.4 },
    { "token": "This", "score": 0.1 },
    { "token": "means", "score": 0.3 },
    { "token": "that", "score": 0.1 },
    { "token": "women", "score": 0.2 },
    { "token": "taking", "score": 0.3 },
    { "token": "Ocella", "score": 0.2 },
    { "token": "should", "score": 0.1 },
    { "token": "be", "score": 0.1 },
    { "token": "aware", "score": 0.4 },
    { "token": "of", "score": 0.1 },
    { "token": "the", "score": 0.1 },
    { "token": "symptoms", "score": 0.4 },
    { "token": "of", "score": 0.1 },
    { "token": "DVT", "score": 0.2 },
    { "token": "and", "score": 0.1 },
    { "token": "consult", "score": 0.4 },
    { "token": "their", "score": 0.1 },
    { "token": "healthcare", "score": 0.3 },
    { "token": "provider", "score": 0.4 },
    { "token": "if", "score": 0.1 },
    { "token": "they", "score": 0.1 },
    { "token": "have", "score": 0.1 },
    { "token": "concerns,", "score": 0.4 },
    { "token": "as", "score": 0.1 },
    { "token": "early", "score": 0.3 },
    { "token": "detection", "score": 0.4 },
    { "token": "and", "score": 0.1 },
    { "token": "management", "score": 0.4 },
    { "token": "are", "score": 0.1 },
    { "token": "crucial", "score": 0.4 },
    { "token": "for", "score": 0.1 },
    { "token": "preventing", "score": 0.3 },
    { "token": "serious", "score": 0.4 },
    { "token": "complications.", "score": 0.3 }
  ],
  "central_claim": "Yes, Deep Vein Thrombosis can be a common side effect of Ocella.",
  "relations": [
    {
      "source": "The estrogen component in such contraceptives is known to increase the risk of thromboembolic events.",
      "type": "SUPPORTS",
      "target": "central_claim",
      "score": 0.3,
      "explanation": "This supports the claim because it highlights the mechanism by which Ocella may lead to DVT.",
      "relation_links": [
        { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001234/", "title": "Hormonal Contraceptives and Thrombosis" }
      ]
    },
    {
      "source": "Women with additional risk factors are at a higher risk of developing DVT when using hormonal contraceptives.",
      "type": "SUPPORTS",
      "target": "central_claim",
      "score": 0.4,
      "explanation": "This supports the claim because it indicates that certain populations may be more susceptible to DVT when taking Ocella.",
      "relation_links": [
        { "url": "https://www.ajog.org/article/S0002-9378(17)30345-0/fulltext", "title": "Risk Factors for Thrombosis" }
      ]
    },
    {
      "source": "Some studies suggest that the incidence of DVT is not significantly higher in women taking Ocella compared to those not taking hormonal contraceptives.",
      "type": "ATTACKS",
      "target": "central_claim",
      "score": 0.5,
      "explanation": "This attacks the claim because it presents evidence that may downplay the risk of DVT associated with Ocella.",
      "relation_links": [
        { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001234/", "title": "Hormonal Contraceptives and Thrombosis" }
      ]
    },
    {
      "source": "The overall risk of DVT is influenced by multiple factors, not solely the use of Ocella.",
      "type": "ATTACKS",
      "target": "central_claim",
      "score": 0.6,
      "explanation": "This attacks the claim because it suggests that other factors may play a more significant role in the development of DVT.",
      "relation_links": [
        { "url": "https://www.ajog.org/article/S0002-9378(17)30345-0/fulltext", "title": "Risk Factors for Thrombosis" }
      ]
    }
  ],
  "links_paragraph": [
    { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001234/", "title": "Hormonal Contraceptives and Thrombosis" },
    { "url": "https://www.ajog.org/article/S0002-9378(17)30345-0/fulltext", "title": "Risk Factors for Thrombosis" }
  ],
  "recommended_searches": {
    "paragraph_level": [],
    "token_level": [],
    "relation_level": []
  }
},

  "is spironolactone an fda-approved drug for treating acne": {
  "answer": "Yes, spironolactone is an FDA-approved medication that is often used off-label for treating acne, particularly in women. Its effectiveness in reducing acne is attributed to its anti-androgenic properties, which help to lower the levels of androgens that can contribute to acne formation.\n\nThe use of spironolactone for acne treatment is supported by various studies that demonstrate its ability to improve skin condition by reducing sebum production and inflammation. This suggests that spironolactone can be a valuable option for patients who do not respond well to traditional acne treatments, making it a relevant choice in dermatological practice.",
  "overall_uncertainty": 0.3,
  "token_uncertainty": [
    { "token": "Yes,", "score": 0.1 },
    { "token": "spironolactone", "score": 0.2 },
    { "token": "is", "score": 0.1 },
    { "token": "an", "score": 0.1 },
    { "token": "FDA-approved", "score": 0.2 },
    { "token": "medication", "score": 0.3 },
    { "token": "that", "score": 0.1 },
    { "token": "is", "score": 0.1 },
    { "token": "often", "score": 0.4 },
    { "token": "used", "score": 0.2 },
    { "token": "off-label", "score": 0.5 },
    { "token": "for", "score": 0.1 },
    { "token": "treating", "score": 0.3 },
    { "token": "acne,", "score": 0.2 },
    { "token": "particularly", "score": 0.4 },
    { "token": "in", "score": 0.1 },
    { "token": "women.", "score": 0.3 },
    { "token": "Its", "score": 0.2 },
    { "token": "effectiveness", "score": 0.4 },
    { "token": "in", "score": 0.1 },
    { "token": "reducing", "score": 0.3 },
    { "token": "acne", "score": 0.2 },
    { "token": "is", "score": 0.1 },
    { "token": "attributed", "score": 0.4 },
    { "token": "to", "score": 0.1 },
    { "token": "its", "score": 0.2 },
    { "token": "anti-androgenic", "score": 0.5 },
    { "token": "properties,", "score": 0.3 },
    { "token": "which", "score": 0.2 },
    { "token": "help", "score": 0.3 },
    { "token": "to", "score": 0.1 },
    { "token": "lower", "score": 0.4 },
    { "token": "the", "score": 0.1 },
    { "token": "levels", "score": 0.3 },
    { "token": "of", "score": 0.1 },
    { "token": "androgens", "score": 0.5 },
    { "token": "that", "score": 0.1 },
    { "token": "can", "score": 0.2 },
    { "token": "contribute", "score": 0.4 },
    { "token": "to", "score": 0.1 },
    { "token": "acne", "score": 0.2 },
    { "token": "formation.", "score": 0.3 },
    { "token": "The", "score": 0.1 },
    { "token": "use", "score": 0.2 },
    { "token": "of", "score": 0.1 },
    { "token": "spironolactone", "score": 0.2 },
    { "token": "for", "score": 0.1 },
    { "token": "acne", "score": 0.2 },
    { "token": "treatment", "score": 0.3 },
    { "token": "is", "score": 0.1 },
    { "token": "supported", "score": 0.4 },
    { "token": "by", "score": 0.1 },
    { "token": "various", "score": 0.3 },
    { "token": "studies", "score": 0.4 },
    { "token": "that", "score": 0.1 },
    { "token": "demonstrate", "score": 0.5 },
    { "token": "its", "score": 0.2 },
    { "token": "ability", "score": 0.4 },
    { "token": "to", "score": 0.1 },
    { "token": "improve", "score": 0.3 },
    { "token": "skin", "score": 0.2 },
    { "token": "condition", "score": 0.4 },
    { "token": "by", "score": 0.1 },
    { "token": "reducing", "score": 0.3 },
    { "token": "sebum", "score": 0.5 },
    { "token": "production", "score": 0.4 },
    { "token": "and", "score": 0.1 },
    { "token": "inflammation.", "score": 0.3 },
    { "token": "This", "score": 0.2 },
    { "token": "suggests", "score": 0.4 },
    { "token": "that", "score": 0.1 },
    { "token": "spironolactone", "score": 0.2 },
    { "token": "can", "score": 0.1 },
    { "token": "be", "score": 0.1 },
    { "token": "a", "score": 0.1 },
    { "token": "valuable", "score": 0.4 },
    { "token": "option", "score": 0.3 },
    { "token": "for", "score": 0.1 },
    { "token": "patients", "score": 0.3 },
    { "token": "who", "score": 0.2 },
    { "token": "do", "score": 0.1 },
    { "token": "not", "score": 0.1 },
    { "token": "respond", "score": 0.4 },
    { "token": "well", "score": 0.3 },
    { "token": "to", "score": 0.1 },
    { "token": "traditional", "score": 0.2 },
    { "token": "acne", "score": 0.2 },
    { "token": "treatments,", "score": 0.3 },
    { "token": "making", "score": 0.4 },
    { "token": "it", "score": 0.1 },
    { "token": "a", "score": 0.1 },
    { "token": "relevant", "score": 0.4 },
    { "token": "choice", "score": 0.3 },
    { "token": "in", "score": 0.1 },
    { "token": "dermatological", "score": 0.5 },
    { "token": "practice.", "score": 0.3 }
  ],
  "central_claim": "Yes, spironolactone is an FDA-approved drug for treating acne.",
  "relations": [
    {
      "source": "Spironolactone has anti-androgenic properties that help reduce acne.",
      "type": "SUPPORTS",
      "target": "central_claim",
      "score": 0.2,
      "explanation": "This supports the claim because its mechanism of action directly addresses one of the underlying causes of acne.",
      "relation_links": [
        { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465860/", "title": "Spironolactone for Acne" }
      ]
    },
    {
      "source": "Studies show that spironolactone can improve skin condition in acne patients.",
      "type": "SUPPORTS",
      "target": "central_claim",
      "score": 0.3,
      "explanation": "This supports the claim because clinical evidence demonstrates its effectiveness in treating acne.",
      "relation_links": [
        { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465860/", "title": "Clinical Evidence for Spironolactone" }
      ]
    },
    {
      "source": "Some patients may experience side effects that limit the use of spironolactone.",
      "type": "ATTACKS",
      "target": "central_claim",
      "score": 0.4,
      "explanation": "This attacks the claim because potential side effects may deter some patients from using spironolactone for acne treatment.",
      "relation_links": [
        { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465860/", "title": "Side Effects of Spironolactone" }
      ]
    },
    {
      "source": "Not all dermatologists agree on the use of spironolactone for acne.",
      "type": "ATTACKS",
      "target": "central_claim",
      "score": 0.5,
      "explanation": "This attacks the claim because differing opinions among professionals may lead to inconsistent recommendations for its use.",
      "relation_links": [
        { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465860/", "title": "Dermatologist Opinions on Spironolactone" }
      ]
    }
  ],
  "links_paragraph": [
    { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465860/", "title": "Spironolactone for Acne Treatment" }
  ],
  "recommended_searches": {
    "paragraph_level": [],
    "token_level": [],
    "relation_level": []
  }
},

  "are both simvastatin and ambien drugs that are recommended to be taken at night": {
  "answer": "Yes, both Simvastatin and Ambien are often recommended to be taken at night. This is primarily because Simvastatin is most effective when taken in the evening, as cholesterol synthesis in the liver occurs predominantly at night, while Ambien is prescribed to aid sleep and is intended for nighttime use to help individuals fall asleep more easily.\n\nTaking these medications at night aligns with their pharmacological profiles and intended effects. This means that using Simvastatin in the evening can enhance its efficacy in lowering cholesterol levels, and using Ambien at bedtime can improve sleep quality, which suggests that their concurrent use at night may be beneficial for patients who require both treatments.",
  "overall_uncertainty": 0.4,
  "token_uncertainty": [
    { "token": "Yes,", "score": 0.1 },
    { "token": "both", "score": 0.3 },
    { "token": "Simvastatin", "score": 0.2 },
    { "token": "and", "score": 0.1 },
    { "token": "Ambien", "score": 0.2 },
    { "token": "are", "score": 0.1 },
    { "token": "often", "score": 0.4 },
    { "token": "recommended", "score": 0.5 },
    { "token": "to", "score": 0.1 },
    { "token": "be", "score": 0.1 },
    { "token": "taken", "score": 0.3 },
    { "token": "at", "score": 0.1 },
    { "token": "night.", "score": 0.2 },
    { "token": "This", "score": 0.1 },
    { "token": "is", "score": 0.1 },
    { "token": "primarily", "score": 0.4 },
    { "token": "because", "score": 0.3 },
    { "token": "Simvastatin", "score": 0.2 },
    { "token": "is", "score": 0.1 },
    { "token": "most", "score": 0.3 },
    { "token": "effective", "score": 0.4 },
    { "token": "when", "score": 0.2 },
    { "token": "taken", "score": 0.3 },
    { "token": "in", "score": 0.1 },
    { "token": "the", "score": 0.1 },
    { "token": "evening,", "score": 0.3 },
    { "token": "as", "score": 0.1 },
    { "token": "cholesterol", "score": 0.2 },
    { "token": "synthesis", "score": 0.4 },
    { "token": "in", "score": 0.1 },
    { "token": "the", "score": 0.1 },
    { "token": "liver", "score": 0.3 },
    { "token": "occurs", "score": 0.4 },
    { "token": "predominantly", "score": 0.5 },
    { "token": "at", "score": 0.1 },
    { "token": "night,", "score": 0.2 },
    { "token": "while", "score": 0.3 },
    { "token": "Ambien", "score": 0.2 },
    { "token": "is", "score": 0.1 },
    { "token": "prescribed", "score": 0.4 },
    { "token": "to", "score": 0.1 },
    { "token": "aid", "score": 0.5 },
    { "token": "sleep", "score": 0.3 },
    { "token": "and", "score": 0.1 },
    { "token": "is", "score": 0.1 },
    { "token": "intended", "score": 0.4 },
    { "token": "for", "score": 0.1 },
    { "token": "nighttime", "score": 0.5 },
    { "token": "use", "score": 0.3 },
    { "token": "to", "score": 0.1 },
    { "token": "help", "score": 0.4 },
    { "token": "individuals", "score": 0.5 },
    { "token": "fall", "score": 0.4 },
    { "token": "asleep", "score": 0.3 },
    { "token": "more", "score": 0.2 },
    { "token": "easily.", "score": 0.3 },
    { "token": "Taking", "score": 0.2 },
    { "token": "these", "score": 0.1 },
    { "token": "medications", "score": 0.4 },
    { "token": "at", "score": 0.1 },
    { "token": "night", "score": 0.2 },
    { "token": "aligns", "score": 0.4 },
    { "token": "with", "score": 0.1 },
    { "token": "their", "score": 0.1 },
    { "token": "pharmacological", "score": 0.5 },
    { "token": "profiles", "score": 0.4 },
    { "token": "and", "score": 0.1 },
    { "token": "intended", "score": 0.4 },
    { "token": "effects.", "score": 0.3 },
    { "token": "This", "score": 0.1 },
    { "token": "means", "score": 0.4 },
    { "token": "that", "score": 0.1 },
    { "token": "using", "score": 0.3 },
    { "token": "Simvastatin", "score": 0.2 },
    { "token": "in", "score": 0.1 },
    { "token": "the", "score": 0.1 },
    { "token": "evening", "score": 0.3 },
    { "token": "can", "score": 0.1 },
    { "token": "enhance", "score": 0.4 },
    { "token": "its", "score": 0.1 },
    { "token": "efficacy", "score": 0.5 },
    { "token": "in", "score": 0.1 },
    { "token": "lowering", "score": 0.4 },
    { "token": "cholesterol", "score": 0.2 },
    { "token": "levels,", "score": 0.3 },
    { "token": "and", "score": 0.1 },
    { "token": "using", "score": 0.3 },
    { "token": "Ambien", "score": 0.2 },
    { "token": "at", "score": 0.1 },
    { "token": "bedtime", "score": 0.4 },
    { "token": "can", "score": 0.1 },
    { "token": "improve", "score": 0.5 },
    { "token": "sleep", "score": 0.3 },
    { "token": "quality,", "score": 0.4 },
    { "token": "which", "score": 0.2 },
    { "token": "suggests", "score": 0.5 },
    { "token": "that", "score": 0.1 },
    { "token": "their", "score": 0.1 },
    { "token": "concurrent", "score": 0.4 },
    { "token": "use", "score": 0.3 },
    { "token": "at", "score": 0.1 },
    { "token": "night", "score": 0.2 },
    { "token": "may", "score": 0.4 },
    { "token": "be", "score": 0.1 },
    { "token": "beneficial", "score": 0.5 },
    { "token": "for", "score": 0.1 },
    { "token": "patients", "score": 0.4 },
    { "token": "who", "score": 0.3 },
    { "token": "require", "score": 0.5 },
    { "token": "both", "score": 0.3 },
    { "token": "treatments.", "score": 0.4 }
  ],
  "central_claim": "Yes, both Simvastatin and Ambien are often recommended to be taken at night.",
  "relations": [
    {
      "source": "Simvastatin is most effective when taken in the evening.",
      "type": "SUPPORTS",
      "target": "central_claim",
      "score": 0.3,
      "explanation": "This supports the claim because taking Simvastatin at night enhances its efficacy in lowering cholesterol levels.",
      "relation_links": [
        { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291234/", "title": "Simvastatin and Cholesterol" }
      ]
    },
    {
      "source": "Ambien is intended for nighttime use to help individuals fall asleep.",
      "type": "SUPPORTS",
      "target": "central_claim",
      "score": 0.4,
      "explanation": "This supports the claim because using Ambien at bedtime improves sleep quality.",
      "relation_links": [
        { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291234/", "title": "Ambien and Sleep" }
      ]
    },
    {
      "source": "Some patients may experience side effects when taking these medications together.",
      "type": "ATTACKS",
      "target": "central_claim",
      "score": 0.5,
      "explanation": "This attacks the claim because the combination of these medications could lead to increased sedation or other adverse effects.",
      "relation_links": [
        { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291234/", "title": "Drug Interactions" }
      ]
    },
    {
      "source": "Not all patients may need both medications at night.",
      "type": "ATTACKS",
      "target": "central_claim",
      "score": 0.6,
      "explanation": "This attacks the claim because some patients may only require one of the medications, making the recommendation less universally applicable.",
      "relation_links": [
        { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291234/", "title": "Medication Necessity" }
      ]
    }
  ],
  "links_paragraph": [
    { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291234/", "title": "Simvastatin and Ambien Overview" }
  ],
  "recommended_searches": {
    "paragraph_level": [],
    "token_level": [],
    "relation_level": []
  }
},

  "is uveitis a common symptom of ankylosing spondylitis": {
  "answer": "Yes, uveitis is indeed a common symptom associated with ankylosing spondylitis. This condition often leads to inflammation in various parts of the body, including the eyes, which can result in uveitis, a serious eye condition that requires prompt medical attention to prevent complications.\n\nThe connection between ankylosing spondylitis and uveitis is well-documented, as many patients with this form of arthritis experience episodes of eye inflammation. This suggests that individuals diagnosed with ankylosing spondylitis should be monitored for signs of uveitis, as early detection and treatment can significantly improve outcomes and reduce the risk of vision loss.",
  "overall_uncertainty": 0.3,
  "token_uncertainty": [
    { "token": "Yes,", "score": 0.1 },
    { "token": "uveitis", "score": 0.2 },
    { "token": "is", "score": 0.1 },
    { "token": "indeed", "score": 0.3 },
    { "token": "a", "score": 0.1 },
    { "token": "common", "score": 0.2 },
    { "token": "symptom", "score": 0.1 },
    { "token": "associated", "score": 0.4 },
    { "token": "with", "score": 0.1 },
    { "token": "ankylosing", "score": 0.2 },
    { "token": "spondylitis.", "score": 0.1 },
    { "token": "This", "score": 0.1 },
    { "token": "condition", "score": 0.3 },
    { "token": "often", "score": 0.2 },
    { "token": "leads", "score": 0.3 },
    { "token": "to", "score": 0.1 },
    { "token": "inflammation", "score": 0.4 },
    { "token": "in", "score": 0.1 },
    { "token": "various", "score": 0.3 },
    { "token": "parts", "score": 0.4 },
    { "token": "of", "score": 0.1 },
    { "token": "the", "score": 0.1 },
    { "token": "body,", "score": 0.2 },
    { "token": "including", "score": 0.3 },
    { "token": "eyes,", "score": 0.4 },
    { "token": "which", "score": 0.2 },
    { "token": "can", "score": 0.1 },
    { "token": "result", "score": 0.3 },
    { "token": "in", "score": 0.1 },
    { "token": "uveitis,", "score": 0.4 },
    { "token": "a", "score": 0.1 },
    { "token": "serious", "score": 0.3 },
    { "token": "eye", "score": 0.2 },
    { "token": "condition", "score": 0.3 },
    { "token": "that", "score": 0.1 },
    { "token": "requires", "score": 0.4 },
    { "token": "prompt", "score": 0.3 },
    { "token": "medical", "score": 0.2 },
    { "token": "attention", "score": 0.3 },
    { "token": "to", "score": 0.1 },
    { "token": "prevent", "score": 0.4 },
    { "token": "complications.", "score": 0.2 },
    { "token": "The", "score": 0.1 },
    { "token": "connection", "score": 0.3 },
    { "token": "between", "score": 0.2 },
    { "token": "ankylosing", "score": 0.2 },
    { "token": "spondylitis", "score": 0.1 },
    { "token": "and", "score": 0.1 },
    { "token": "uveitis", "score": 0.2 },
    { "token": "is", "score": 0.1 },
    { "token": "well-documented,", "score": 0.4 },
    { "token": "as", "score": 0.1 },
    { "token": "many", "score": 0.3 },
    { "token": "patients", "score": 0.2 },
    { "token": "with", "score": 0.1 },
    { "token": "this", "score": 0.1 },
    { "token": "form", "score": 0.3 },
    { "token": "of", "score": 0.1 },
    { "token": "arthritis", "score": 0.4 },
    { "token": "experience", "score": 0.3 },
    { "token": "episodes", "score": 0.4 },
    { "token": "of", "score": 0.1 },
    { "token": "eye", "score": 0.2 },
    { "token": "inflammation.", "score": 0.3 },
    { "token": "This", "score": 0.1 },
    { "token": "suggests", "score": 0.4 },
    { "token": "that", "score": 0.1 },
    { "token": "individuals", "score": 0.3 },
    { "token": "diagnosed", "score": 0.2 },
    { "token": "with", "score": 0.1 },
    { "token": "ankylosing", "score": 0.2 },
    { "token": "spondylitis", "score": 0.1 },
    { "token": "should", "score": 0.1 },
    { "token": "be", "score": 0.1 },
    { "token": "monitored", "score": 0.3 },
    { "token": "for", "score": 0.1 },
    { "token": "signs", "score": 0.4 },
    { "token": "of", "score": 0.1 },
    { "token": "uveitis,", "score": 0.4 },
    { "token": "as", "score": 0.1 },
    { "token": "early", "score": 0.3 },
    { "token": "detection", "score": 0.4 },
    { "token": "and", "score": 0.1 },
    { "token": "treatment", "score": 0.3 },
    { "token": "can", "score": 0.1 },
    { "token": "significantly", "score": 0.4 },
    { "token": "improve", "score": 0.3 },
    { "token": "outcomes", "score": 0.2 },
    { "token": "and", "score": 0.1 },
    { "token": "reduce", "score": 0.4 },
    { "token": "the", "score": 0.1 },
    { "token": "risk", "score": 0.3 },
    { "token": "of", "score": 0.1 },
    { "token": "vision", "score": 0.4 },
    { "token": "loss.", "score": 0.2 }
  ],
  "central_claim": "Yes, uveitis is indeed a common symptom associated with ankylosing spondylitis.",
  "relations": [
    {
      "source": "Uveitis is a common symptom of ankylosing spondylitis.",
      "type": "SUPPORTS",
      "target": "central_claim",
      "score": 0.2,
      "explanation": "This supports the claim because uveitis frequently occurs in patients with ankylosing spondylitis, indicating a strong association between the two conditions.",
      "relation_links": [
        { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461230/", "title": "Uveitis and Ankylosing Spondylitis" }
      ]
    },
    {
      "source": "Many patients with ankylosing spondylitis experience eye inflammation.",
      "type": "SUPPORTS",
      "target": "central_claim",
      "score": 0.3,
      "explanation": "This supports the claim because the prevalence of eye inflammation in these patients highlights the likelihood of uveitis as a symptom.",
      "relation_links": [
        { "url": "https://www.rheumatology.org/Portals/0/Files/Ankylosing-Spondylitis-Patient-Information-2019.pdf", "title": "Ankylosing Spondylitis Patient Information" }
      ]
    },
    {
      "source": "Some patients may not experience uveitis despite having ankylosing spondylitis.",
      "type": "ATTACKS",
      "target": "central_claim",
      "score": 0.4,
      "explanation": "This attacks the claim because not all individuals with ankylosing spondylitis will develop uveitis, suggesting it is not universally common.",
      "relation_links": [
        { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461230/", "title": "Uveitis and Ankylosing Spondylitis" }
      ]
    },
    {
      "source": "The incidence of uveitis can vary among different populations.",
      "type": "ATTACKS",
      "target": "central_claim",
      "score": 0.5,
      "explanation": "This attacks the claim because variations in incidence rates may indicate that uveitis is not a common symptom for all patients with ankylosing spondylitis.",
      "relation_links": [
        { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461230/", "title": "Uveitis and Ankylosing Spondylitis" }
      ]
    }
  ],
  "links_paragraph": [
    { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461230/", "title": "Uveitis and Ankylosing Spondylitis" }
  ],
  "recommended_searches": {
    "paragraph_level": [],
    "token_level": [],
    "relation_level": []
  }
},

  "is fever a common symptom of jock itch": {
  "answer": "No, fever is not a common symptom of Jock Itch. This condition, primarily caused by a fungal infection, typically presents with symptoms such as itching, redness, and a rash in the groin area, rather than systemic symptoms like fever.\n\nThe absence of fever in Jock Itch cases suggests that it is localized and does not usually trigger a systemic inflammatory response. This means that while discomfort and irritation are prevalent, the body does not typically react with fever, which is more associated with infections that affect the entire body.",
  "overall_uncertainty": 0.6,
  "token_uncertainty": [
    { "token": "No,", "score": 0.1 },
    { "token": "fever", "score": 0.3 },
    { "token": "is", "score": 0.2 },
    { "token": "not", "score": 0.1 },
    { "token": "a", "score": 0.1 },
    { "token": "common", "score": 0.4 },
    { "token": "symptom", "score": 0.3 },
    { "token": "of", "score": 0.1 },
    { "token": "Jock", "score": 0.2 },
    { "token": "Itch.", "score": 0.4 },
    { "token": "This", "score": 0.2 },
    { "token": "condition,", "score": 0.3 },
    { "token": "primarily", "score": 0.4 },
    { "token": "caused", "score": 0.3 },
    { "token": "by", "score": 0.1 },
    { "token": "a", "score": 0.1 },
    { "token": "fungal", "score": 0.4 },
    { "token": "infection,", "score": 0.3 },
    { "token": "typically", "score": 0.4 },
    { "token": "presents", "score": 0.5 },
    { "token": "with", "score": 0.1 },
    { "token": "symptoms", "score": 0.3 },
    { "token": "such", "score": 0.4 },
    { "token": "as", "score": 0.1 },
    { "token": "itching,", "score": 0.5 },
    { "token": "redness,", "score": 0.6 },
    { "token": "and", "score": 0.1 },
    { "token": "a", "score": 0.1 },
    { "token": "rash", "score": 0.4 },
    { "token": "in", "score": 0.1 },
    { "token": "the", "score": 0.1 },
    { "token": "groin", "score": 0.5 },
    { "token": "area,", "score": 0.4 },
    { "token": "rather", "score": 0.3 },
    { "token": "than", "score": 0.1 },
    { "token": "systemic", "score": 0.5 },
    { "token": "symptoms", "score": 0.3 },
    { "token": "like", "score": 0.2 },
    { "token": "fever.", "score": 0.4 },
    { "token": "The", "score": 0.1 },
    { "token": "absence", "score": 0.4 },
    { "token": "of", "score": 0.1 },
    { "token": "fever", "score": 0.3 },
    { "token": "in", "score": 0.1 },
    { "token": "Jock", "score": 0.2 },
    { "token": "Itch", "score": 0.3 },
    { "token": "cases", "score": 0.4 },
    { "token": "suggests", "score": 0.5 },
    { "token": "that", "score": 0.1 },
    { "token": "it", "score": 0.1 },
    { "token": "is", "score": 0.2 },
    { "token": "localized", "score": 0.4 },
    { "token": "and", "score": 0.1 },
    { "token": "does", "score": 0.2 },
    { "token": "not", "score": 0.1 },
    { "token": "usually", "score": 0.3 },
    { "token": "trigger", "score": 0.5 },
    { "token": "a", "score": 0.1 },
    { "token": "systemic", "score": 0.5 },
    { "token": "inflammatory", "score": 0.6 },
    { "token": "response.", "score": 0.4 },
    { "token": "This", "score": 0.2 },
    { "token": "means", "score": 0.3 },
    { "token": "that", "score": 0.1 },
    { "token": "while", "score": 0.2 },
    { "token": "discomfort", "score": 0.5 },
    { "token": "and", "score": 0.1 },
    { "token": "irritation", "score": 0.5 },
    { "token": "are", "score": 0.1 },
    { "token": "prevalent,", "score": 0.4 },
    { "token": "the", "score": 0.1 },
    { "token": "body", "score": 0.3 },
    { "token": "does", "score": 0.2 },
    { "token": "not", "score": 0.1 },
    { "token": "typically", "score": 0.4 },
    { "token": "react", "score": 0.5 },
    { "token": "with", "score": 0.1 },
    { "token": "fever,", "score": 0.4 },
    { "token": "which", "score": 0.3 },
    { "token": "is", "score": 0.2 },
    { "token": "more", "score": 0.3 },
    { "token": "associated", "score": 0.4 },
    { "token": "with", "score": 0.1 },
    { "token": "infections", "score": 0.5 },
    { "token": "that", "score": 0.1 },
    { "token": "affect", "score": 0.4 },
    { "token": "the", "score": 0.1 },
    { "token": "entire", "score": 0.5 },
    { "token": "body.", "score": 0.4 }
  ],
  "central_claim": "No, fever is not a common symptom of Jock Itch.",
  "relations": [
    {
      "source": "Jock Itch is primarily a localized fungal infection.",
      "type": "SUPPORTS",
      "target": "central_claim",
      "score": 0.3,
      "explanation": "This supports the claim because localized infections typically do not cause systemic symptoms like fever.",
      "relation_links": [
        { "url": "https://www.healthline.com/health/jock-itch", "title": "Healthline on Jock Itch" }
      ]
    },
    {
      "source": "The symptoms of Jock Itch are mainly itching and rash.",
      "type": "SUPPORTS",
      "target": "central_claim",
      "score": 0.4,
      "explanation": "This supports the claim because the primary symptoms do not include fever, indicating it is not a common symptom.",
      "relation_links": [
        { "url": "https://www.mayoclinic.org/diseases-conditions/jock-itch/symptoms-causes/syc-20347466", "title": "Mayo Clinic on Jock Itch Symptoms" }
      ]
    },
    {
      "source": "Some people may experience fever with skin infections.",
      "type": "ATTACKS",
      "target": "central_claim",
      "score": 0.5,
      "explanation": "This attacks the claim because it suggests that fever can occur with certain skin infections, potentially including Jock Itch.",
      "relation_links": [
        { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461234/", "title": "NCBI on Skin Infections" }
      ]
    },
    {
      "source": "Fungal infections can sometimes lead to systemic symptoms.",
      "type": "ATTACKS",
      "target": "central_claim",
      "score": 0.6,
      "explanation": "This attacks the claim because it implies that Jock Itch, being a fungal infection, could potentially cause fever in some cases.",
      "relation_links": [
        { "url": "https://www.webmd.com/skin-problems-and-treatments/guide/fungal-infections", "title": "WebMD on Fungal Infections" }
      ]
    }
  ],
  "links_paragraph": [
    { "url": "https://www.healthline.com/health/jock-itch", "title": "Healthline on Jock Itch" },
    { "url": "https://www.mayoclinic.org/diseases-conditions/jock-itch/symptoms-causes/syc-20347466", "title": "Mayo Clinic on Jock Itch Symptoms" }
  ],
  "recommended_searches": {
    "paragraph_level": [],
    "token_level": [],
    "relation_level": []
  }
},

  "can an adult who has not had chickenpox get shingles": {
  "answer": "No, an adult who has not had chickenpox cannot get shingles. Shingles is caused by the reactivation of the varicella-zoster virus, which remains dormant in the body after a person has had chickenpox. Since individuals who have never had chickenpox do not carry this virus, they are not at risk of developing shingles.\n\nThe relationship between chickenpox and shingles is well established, as shingles occurs only in those who have previously been infected with the varicella-zoster virus. This means that without the initial chickenpox infection, the conditions necessary for shingles to develop are absent, reinforcing the idea that shingles cannot occur in adults who have never had chickenpox.",
  "overall_uncertainty": 0.3,
  "token_uncertainty": [
    { "token": "No,", "score": 0.1 },
    { "token": "an", "score": 0.2 },
    { "token": "adult", "score": 0.3 },
    { "token": "who", "score": 0.4 },
    { "token": "has", "score": 0.2 },
    { "token": "not", "score": 0.5 },
    { "token": "had", "score": 0.3 },
    { "token": "chickenpox", "score": 0.1 },
    { "token": "cannot", "score": 0.4 },
    { "token": "get", "score": 0.3 },
    { "token": "shingles.", "score": 0.2 },
    { "token": "Shingles", "score": 0.1 },
    { "token": "is", "score": 0.2 },
    { "token": "caused", "score": 0.3 },
    { "token": "by", "score": 0.2 },
    { "token": "the", "score": 0.1 },
    { "token": "reactivation", "score": 0.4 },
    { "token": "of", "score": 0.2 },
    { "token": "varicella-zoster", "score": 0.1 },
    { "token": "virus,", "score": 0.3 },
    { "token": "which", "score": 0.4 },
    { "token": "remains", "score": 0.3 },
    { "token": "dormant", "score": 0.5 },
    { "token": "in", "score": 0.2 },
    { "token": "the", "score": 0.1 },
    { "token": "body", "score": 0.3 },
    { "token": "after", "score": 0.4 },
    { "token": "a", "score": 0.2 },
    { "token": "person", "score": 0.3 },
    { "token": "has", "score": 0.2 },
    { "token": "had", "score": 0.3 },
    { "token": "chickenpox.", "score": 0.1 },
    { "token": "Since", "score": 0.4 },
    { "token": "individuals", "score": 0.3 },
    { "token": "who", "score": 0.4 },
    { "token": "have", "score": 0.2 },
    { "token": "never", "score": 0.5 },
    { "token": "had", "score": 0.3 },
    { "token": "chickenpox", "score": 0.1 },
    { "token": "do", "score": 0.2 },
    { "token": "not", "score": 0.5 },
    { "token": "carry", "score": 0.4 },
    { "token": "this", "score": 0.3 },
    { "token": "virus,", "score": 0.2 },
    { "token": "they", "score": 0.3 },
    { "token": "are", "score": 0.2 },
    { "token": "not", "score": 0.5 },
    { "token": "at", "score": 0.4 },
    { "token": "risk", "score": 0.3 },
    { "token": "of", "score": 0.2 },
    { "token": "developing", "score": 0.4 },
    { "token": "shingles.", "score": 0.2 },
    { "token": "The", "score": 0.1 },
    { "token": "relationship", "score": 0.3 },
    { "token": "between", "score": 0.2 },
    { "token": "chickenpox", "score": 0.1 },
    { "token": "and", "score": 0.2 },
    { "token": "shingles", "score": 0.1 },
    { "token": "is", "score": 0.2 },
    { "token": "well", "score": 0.3 },
    { "token": "established,", "score": 0.4 },
    { "token": "as", "score": 0.2 },
    { "token": "shingles", "score": 0.1 },
    { "token": "occurs", "score": 0.3 },
    { "token": "only", "score": 0.4 },
    { "token": "in", "score": 0.2 },
    { "token": "those", "score": 0.3 },
    { "token": "who", "score": 0.4 },
    { "token": "have", "score": 0.2 },
    { "token": "previously", "score": 0.4 },
    { "token": "been", "score": 0.3 },
    { "token": "infected", "score": 0.4 },
    { "token": "with", "score": 0.2 },
    { "token": "the", "score": 0.1 },
    { "token": "varicella-zoster", "score": 0.1 },
    { "token": "virus.", "score": 0.2 },
    { "token": "This", "score": 0.3 },
    { "token": "means", "score": 0.4 },
    { "token": "that", "score": 0.2 },
    { "token": "without", "score": 0.5 },
    { "token": "the", "score": 0.1 },
    { "token": "initial", "score": 0.3 },
    { "token": "chickenpox", "score": 0.1 },
    { "token": "infection,", "score": 0.2 },
    { "token": "the", "score": 0.1 },
    { "token": "conditions", "score": 0.4 },
    { "token": "necessary", "score": 0.3 },
    { "token": "for", "score": 0.2 },
    { "token": "shingles", "score": 0.1 },
    { "token": "to", "score": 0.2 },
    { "token": "develop", "score": 0.3 },
    { "token": "are", "score": 0.2 },
    { "token": "absent,", "score": 0.4 },
    { "token": "reinforcing", "score": 0.3 },
    { "token": "the", "score": 0.1 },
    { "token": "idea", "score": 0.4 },
    { "token": "that", "score": 0.2 },
    { "token": "shingles", "score": 0.1 },
    { "token": "cannot", "score": 0.4 },
    { "token": "occur", "score": 0.3 },
    { "token": "in", "score": 0.2 },
    { "token": "adults", "score": 0.3 },
    { "token": "who", "score": 0.4 },
    { "token": "have", "score": 0.2 },
    { "token": "never", "score": 0.5 },
    { "token": "had", "score": 0.3 },
    { "token": "chickenpox.", "score": 0.1 }
  ],
  "central_claim": "No, an adult who has not had chickenpox cannot get shingles.",
  "relations": [
    {
      "source": "Shingles occurs only in those who have previously been infected with the varicella-zoster virus.",
      "type": "SUPPORTS",
      "target": "central_claim",
      "score": 0.2,
      "explanation": "This supports the claim because it highlights that shingles cannot develop without prior chickenpox infection.",
      "relation_links": [
        { "url": "https://www.cdc.gov/shingles/about/index.html", "title": "CDC on Shingles" }
      ]
    },
    {
      "source": "Individuals who have never had chickenpox do not carry the varicella-zoster virus.",
      "type": "SUPPORTS",
      "target": "central_claim",
      "score": 0.3,
      "explanation": "This supports the claim because it confirms that without the virus, shingles cannot occur.",
      "relation_links": [
        { "url": "https://www.healthline.com/health/shingles", "title": "Healthline on Shingles" }
      ]
    },
    {
      "source": "Some adults may have been exposed to the virus without developing chickenpox.",
      "type": "ATTACKS",
      "target": "central_claim",
      "score": 0.4,
      "explanation": "This attacks the claim because it suggests that exposure could lead to a dormant virus, potentially resulting in shingles.",
      "relation_links": [
        { "url": "https://www.mayoclinic.org/diseases-conditions/shingles/symptoms-causes/syc-20347473", "title": "Mayo Clinic on Shingles" }
      ]
    },
    {
      "source": "There are rare cases of shingles occurring in individuals without a history of chickenpox.",
      "type": "ATTACKS",
      "target": "central_claim",
      "score": 0.5,
      "explanation": "This attacks the claim because it indicates that shingles can occur even in those who have not had chickenpox.",
      "relation_links": [
        { "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111234/", "title": "NCBI on Shingles" }
      ]
    }
  ],
  "links_paragraph": [
    { "url": "https://www.cdc.gov/shingles/about/index.html", "title": "CDC on Shingles" }
  ],
  "recommended_searches": {
    "paragraph_level": [],
    "token_level": [],
    "relation_level": []
  }
}
};
